Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing
Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy.
EP: 1.Clinical and Economic Burden of Schizophrenia
EP: 2.Symptoms Associated with Schizophrenia
EP: 3.Risk Factors for Schizophrenia
EP: 4.Challenges of Early and Accurate Diagnosis in Schizophrenia
EP: 5.Exploring Schizophrenia Progression and Its Impact on Quality of Life
EP: 6.Consequences of Relapse in Schizophrenia Care
EP: 7.“Addressing Social Determinants of Health and Unmet Needs in Schizophrenia”
EP: 8.Current Treatment Guidelines for Schizophrenia
Now Viewing
EP: 9.First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing
EP: 10.Switching Therapies, Managing Adverse Effects, and Adherence Challenges
Panelists discuss how first-generation antipsychotics primarily manage positive symptoms but often cause extrapyramidal adverse effects, while second-generation options offer broader efficacy with improved tolerability.
Panelists discuss how choosing between oral and long-acting injectable formulations depends on patient adherence history, preference, and adverse effect risk.
Panelists discuss how careful sequencing and cycling through medications should minimize relapse risk while balancing safety, efficacy, and patient satisfaction.
Related Videos
Related Content
